Serveur d'exploration sur les peptides biopesticides - Exploration (Accueil)

Index « Mesh.i » - entrée « Drug Therapy, Combination »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Therapy < Drug Therapy, Combination < Drug Therapy, Computer-Assisted  Facettes :

List of bibliographic references indexed by Drug Therapy, Combination

Number of relevant bibliographic references: 158.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000004 (2020) S. Javor [Italie] ; A. Salsano [Italie]Why not consider an endothelin receptor antagonist against SARS-CoV-2?
000012 (2020) Karim Parastouei [Iran] ; Farid Solaymani-Mohammadi [États-Unis] ; Mohammad Reza Shiri-Shahsavar [Iran] ; Reza Chahardoli [Iran] ; Ateke Mousavi Nasl-Khameneh [Iran] ; Mehdi Borhani Zarandi [Iran] ; Somayeh Ghotloo [Iran] ; Ali Akbar Saboor-Yaraghi [Iran]The effect of calcitriol and all-trans retinoic acid on T-bet, IFN-γ, GATA3 and IL-4 genes expression in experimental autoimmune encephalomyelitis.
000014 (2020) Francesco Ferrara [Italie] ; Giovanni Granata [Italie] ; Chiara Pelliccia [Italie] ; Raffaele La Porta [Italie] ; Antonio Vitiello [Italie]The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
000055 (2020) Walid Hamdy El-Tantawy [Égypte] ; Abeer Temraz [Arabie saoudite, Égypte]Natural products for the management of the hepatitis C virus: a biochemical review.
000117 (2020) Yaoxiang Zhu [République populaire de Chine] ; Ruijue Liu [République populaire de Chine] ; Zhenglin Shen [République populaire de Chine] ; Guoqiang Cai [République populaire de Chine]Combination of luteolin and lycopene effectively protect against the "two-hit" in NAFLD through Sirt1/AMPK signal pathway.
000255 (2019) Gian Paolo Fadini [Italie] ; Veronica Sciannameo [Italie] ; Ivano Franzetti [Italie] ; Daniele Bottigliengo [Italie] ; Paola D'Angelo [Italie] ; Carmela Vinci [Italie] ; Paola Berchialla [Italie] ; Salvatore Arena [Italie] ; Raffaella Buzzetti [Italie] ; Angelo Avogaro [Italie]Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study.
000362 (2019) Bee Luan Khoo [Singapour] ; Gianluca Grenci [Singapour] ; Joey Sze Yun Lim [Singapour] ; Yan Ping Lim [Singapour] ; July Fong [Singapour] ; Wei Hseun Yeap [Singapour] ; Su Bin Lim [Singapour] ; Song Lin Chua [Singapour] ; Siew Cheng Wong [Singapour] ; Yoon-Sim Yap [Singapour] ; Soo Chin Lee [Singapour] ; Chwee Teck Lim [Singapour] ; Jongyoon Han [Singapour, États-Unis]Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention.
000436 (2019) Yong Liu [République populaire de Chine] ; Huifan Ji [République populaire de Chine] ; Pingwei Zhao [République populaire de Chine] ; Hongqing Yan [République populaire de Chine] ; Yanjun Cai [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Xiaoli Hu [République populaire de Chine] ; Xiguang Sun [République populaire de Chine] ; Yanfang Jiang [République populaire de Chine]Follicular helper T cell and memory B cell immunity in CHC patients.
000477 (2019) Davide Giuseppe Ribaldone [Italie] ; Rinaldo Pellicano [Italie] ; Marta Vernero [Italie] ; Gian Paolo Caviglia [Italie] ; Giorgio Maria Saracco [Italie] ; Mario Morino [Italie] ; Marco Astegiano [Italie]Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis.
000663 (2018) B R Branchford [États-Unis] ; T J Stalker [États-Unis] ; L. Law [États-Unis] ; G. Acevedo [États-Unis] ; S. Sather [États-Unis] ; C. Brzezinski [États-Unis] ; K M Wilson [États-Unis] ; K. Minson [États-Unis] ; A B Lee-Sherick [États-Unis] ; P. Davizon-Castillo [États-Unis] ; C. Ng [États-Unis] ; W. Zhang [États-Unis] ; K B Neeves [États-Unis] ; S R Lentz [États-Unis] ; X. Wang [États-Unis] ; S V Frye [États-Unis] ; H. Shelton Earp [États-Unis] ; D. Deryckere [États-Unis] ; L F Brass [États-Unis] ; D K Graham [États-Unis] ; J A Di Paola [États-Unis]The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis.
000811 (2018) Daniel A. Briere [États-Unis] ; Ana B. Bueno [Espagne] ; Ellen J. Gunn [États-Unis] ; M Dodson Michael [États-Unis] ; Kyle W. Sloop [Oman]Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery.
000830 (2018) Domenico Accili [États-Unis]Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.
000934 (2018) Enyuan Shang [États-Unis] ; Yiru Zhang [États-Unis] ; Chang Shu [États-Unis] ; Chiaki Tsuge Ishida [États-Unis] ; Elena Bianchetti [États-Unis] ; Mike-Andrew Westhoff [Allemagne] ; Georg Karpel-Massler [Allemagne] ; Markus D. Siegelin [États-Unis]Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems.
000946 (2018) Puneet Gaitonde [États-Unis] ; Felipe K. Hurtado [États-Unis] ; Parag Garhyan [États-Unis] ; Jenny Y. Chien [États-Unis] ; Stephan Schmidt [États-Unis]Development and Qualification of a Drug-Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials.
000979 (2018) Ruoqiong Cao [République populaire de Chine, États-Unis] ; Garrett Teskey [États-Unis] ; Hicret Islamoglu [États-Unis] ; Rachel Abrahem [États-Unis] ; Shalok Munjal [États-Unis] ; Karo Gyurjian [États-Unis] ; Li Zhong [République populaire de Chine, États-Unis] ; Vishwanath Venketaraman [États-Unis]Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
000989 (2018) Williams E E. Nabofa [Nigeria] ; Oluwadamilola O. Alashe [Nigeria] ; Oyetunde T. Oyeyemi [Nigeria] ; Alfred F. Attah [Nigeria] ; Ademola A. Oyagbemi [Nigeria] ; Temidayo O. Omobowale [Nigeria] ; Adeolu A. Adedapo [Nigeria] ; Akinola R A. Alada [Nigeria]Cardioprotective Effects of Curcumin-Nisin Based Poly Lactic Acid Nanoparticle on Myocardial Infarction in Guinea Pigs.
000A09 (2018) Hiddo J L. Heerspink [Pays-Bas] ; Dennis L. Andress [États-Unis] ; George Bakris [États-Unis] ; John J. Brennan [États-Unis] ; Ricardo Correa-Rotter [Mexique] ; Fan Fan Hou [République populaire de Chine] ; Dalane W. Kitzman [États-Unis] ; Donald Kohan [États-Unis] ; Hirofumi Makino [Japon] ; John Mcmurray [Royaume-Uni] ; Vlado Perkovic [Australie] ; Sheldon Tobe [Canada] ; Melissa Wigderson [États-Unis] ; Tingting Yi [États-Unis] ; Hans-Henrik Parving [Danemark] ; Dick De Zeeuw [Pays-Bas]Baseline characteristics and enrichment results from the SONAR trial.
000A63 (2018) Mina Abdolahi [Iran] ; Payam Sarraf [Iran] ; Mohammad Hassan Javanbakht [Iran] ; Niyaz Mohammadzadeh Honarvar [Iran] ; Mahsa Hatami [Iran] ; Neda Soveyd [Iran] ; Abbas Tafakhori [Iran] ; Mohsen Sedighiyan [Iran] ; Mona Djalali [Iran] ; Arash Jafarieh [Iran] ; Yousef Masoudian [Iran] ; Mahmoud Djalali [Iran]A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study.
000D84 (2017) Cloé Comarmond [France] ; Marlène Garrido [France] ; Stanislas Pol [France] ; Anne-Claire Desbois [France] ; Myrto Costopoulos [France] ; Magali Le Garff-Tavernier [France] ; Si Nafa Si Ahmed [France] ; Laurent Alric [France] ; Hélène Fontaine [France] ; Bertrand Bellier [France] ; Anna Maciejewski [France] ; Michelle Rosenzwajg [France] ; David Klatzmann [France] ; Lucile Musset [France] ; Thierry Poynard [France] ; Patrice Cacoub [France] ; David Saadoun [France]Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
000E26 (2017) Mohd Nizam Mansoori [Inde] ; Priyanka Shukla [Inde] ; Divya Singh [Inde]Combination of PTH (1-34) with anti-IL17 prevents bone loss by inhibiting IL-17/N-cadherin mediated disruption of PTHR1/LRP-6 interaction.
000E50 (2017) Takuya Furuta [Japon] ; Hemragul Sabit [Japon] ; Yu Dong [Japon] ; Katsuyoshi Miyashita [Japon] ; Masashi Kinoshita [Japon] ; Naoyuki Uchiyama [Japon] ; Yasuhiko Hayashi [Japon] ; Yutaka Hayashi [Japon] ; Toshinari Minamoto [Japon] ; Mitsutoshi Nakada [Japon]Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/BiopestPeptidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Drug Therapy, Combination" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Drug Therapy, Combination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    BiopestPeptidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Therapy, Combination
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 19:22:35 2020. Site generation: Thu Nov 19 19:33:26 2020